Endoscopic submucosal dissection for an early-stage neuroendocrine carcinoma composited with squamous cell dysplasia

Endoscopy 2022; 54(10): E573-E575
DOI: 10.1055/a-1682-7012

E-Videos

Meng-Jiang He‡^*

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

,

Xin-Yang Liu‡^*

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

,

Tian-Yin Chen

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

,

Ping-Hong Zhou

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

,

Yi-Qun Zhang

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

References
1 Lu X, Luo J, Ling Y. et al. Management of small cell carcinoma of esophagus in China. J Gastrointest Surg 2013; 17: 1181-1187
2 Fujihara S, Kobayashi M, Nishi M. et al. Composite neuroendocrine carcinoma and squamous cell carcinoma with regional lymph node metastasis: a case report. J Med Case Rep 2018; 12: 227
3 Watanabe K, Hikichi T, Sato M. et al. A case of endocrine cell carcinoma combined with squamous cell carcinoma of the esophagus resected by endoscopic submucosal dissection. Fukushima J Med Sci 2014; 60: 187-191
4 Xu L, Li Y, Liu X. et al. Treatment strategies and prognostic factors of limited-stage primary small cell carcinoma of the esophagus. J Thorac Oncol 2017; 12: 1834-1844
5 Ishikawa KakiyaY, Nagami Y, Fujiwara Y. Intramucosal esophageal neuroendocrine carcinoma treated with endoscopic submucosal dissection and chemotherapy. Dig Endosc 2019; 31: 466